ANNX Stock Analysis: Buy, Sell, or Hold?
ANNX - Annexon, Inc. Common Stock
$5.36
-0.18 (-3.25%)
▼
5d:
-0.09%
30d:
-1.29%
90d:
+6.35%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 18, 2026
Smart Money Distribution
ANNX is up 4.3% this week, but smart money is buying puts. Top strike: $5 2026-05-15 with 8 OI. Put ratio: 100% View Scanner →
Strength: 7.1/10
Get Alerted When ANNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ANNX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ANNX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: ANNX is currently trading at $5.36, which is considered fair relative to its 30-day fair value range of $5.10 to $5.69.
Technical Outlook: Technically, ANNX is in a uptrend. Immediate support is located at $4.86, while resistance sits at $6.10. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: ANNX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.33 (+167.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ANNX is in a uptrend. Immediate support is located at $4.86, while resistance sits at $6.10. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: ANNX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.33 (+167.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$5.10 -
$5.69
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 167.4% below Wall St target ($14.33)
Fair Price Analysis
30-Day Fair Range
$5.10 -
$5.69
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$4.86
Resistance Level
$6.10
Current Trend
Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.50
Wall Street Target
$14.33
(+167.4%)
Share & Embed Analysis
Last updated: April 02, 2026 7:22 AM ET
Data refreshes hourly during market hours. Next update: 8:22 AM
Data refreshes hourly during market hours. Next update: 8:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANNX showing a specific setup today?
Insider Activity (6 Months)
9
Buys
5
Sells
+
Net
INSIDERS BUYING
Recent Transactions
William H Carson
BUY
8000 shares
2026-03-10
Dean Richard Artis
SELL
5290 shares
2026-02-18
Jamie Dananberg
SELL
5290 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 59 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 45 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 55 HOLD |
